Testing for hereditary breast and ovarian cancer in the southeastern United States

被引:15
|
作者
Miron, A
Schildkraut, JM
Rimer, BK
Winer, EP
Skinner, CS
Futreal, PA
Culler, D
Calingaert, B
Clark, S
Marcom, PK
Iglehart, JD
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Family & Community Med, Durham, NC 27710 USA
[4] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1097/00000658-200005000-00002
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives To detail characterization of mutations and uncharacterized variants in the breast cancer susceptibility genes BRCA1 and BRCA2, as observed in a population of breast cancer patients from the southeastern United States, and to examine baseline characteristics of women referred for counseling and testing and provide a preliminary look at how counseling and testing affected intentions toward prophylactic surgery, Background Mutations in the BRCA1 and BRCA2 genes give rise to a dramatically increased risk of developing breast or ovarian cancer or both. There are many reports about special populations in which deleterious mutations are present ata high frequency. it is useful to study these genes in more heterogeneous populations, reflecting different geographic regions. Interest in preventive surgery for gene carriers is high in women and their surgeons. Methods Women were recruited through a prospective clinical trial of counseling and free genetic testing. BRCA1 and BRCA2 were screened for mutations using standard techniques, and results were given to participants. Baseline questionnaires determined interest in preventive surgery at the beginning of the study. Follow-up questionnaires for those who completed testing surveyed interest in prophylactic surgery after counseling and receiving test results, Results OC 213 women who completed counseling and testing, 44 (20.6%) had 29 separate mutations; there were II Jewish women carrying three founder mutations. Twenty-eight women (13.1%) had uncharacterized variants in BRCA1 or BRCA2; nine were not previously reported. Women overestimated their chances of possessing a deleterious gene mutation compared to a statistical estimate of carrier risk, A number of women changed their intentions toward preventive surgery after genetic counseling and testing, Conclusions Hereditary breast cancer due to mutations in BRCA1 and BRCA2 was a heterogeneous syndrome in the southeastern United States. Most mutations were seen just once, and uncharacterized variants were common and of uncertain clinical significance. in general, positive test results tended to reinforce intentions toward prophylactic surgery. in contrast, women not interested in surgery at the time of entry tended to remain reluctant after testing and counseling.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 50 条
  • [1] Testing for hereditary breast and ovarian cancer in the southeastern United States - Discussion
    Holder, WD
    Bland, KI
    Copeland, EM
    Iglehart, JD
    ANNALS OF SURGERY, 2000, 231 (05) : 632 - 634
  • [2] National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer
    Childers, Kimberly K.
    Maggard-Gibbons, Melinda
    Macinko, James
    Childers, Christopher P.
    JAMA ONCOLOGY, 2018, 4 (06) : 876 - 879
  • [3] Hereditary Breast and Ovarian Cancer Testing in the Genomic Era
    Greville-Heygate, Stephanie L.
    Eccles, Diana M.
    Side, Lucy E.
    JAMA ONCOLOGY, 2019, 5 (01) : 58 - 59
  • [4] Genetic testing for hereditary breast and ovarian cancer: Responsibility and choice
    d'Agincourt-Canning, L
    QUALITATIVE HEALTH RESEARCH, 2006, 16 (01) : 97 - 118
  • [5] Clinical evaluation of multigene testing for hereditary breast and ovarian cancer
    Ellisen, Leif
    Kurian, Allison
    Lincoln, Stephen
    Desmond, Andrea
    Mills, Meredith
    Shannon, Kristen
    Gabree, Michelle
    Anderson, Michael
    Kobayashi, Yuya
    Monzon, Federico
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [6] Genetic testing for patients at risk of hereditary breast and ovarian cancer
    DeTroye, Alisha
    Gabbett, Kayla
    Yi, Cheryl
    Judice, Melanie
    Luu, Victor
    Nelson, Brittany
    Gregory, Tanya
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (10): : 48 - 52
  • [7] Technical evaluation of multigene testing for hereditary breast and ovarian cancer
    Lincoln, Stephen
    Kurian, Allison
    Desmond, Andrea
    Nilsen, Geoffrey
    Jacobs, Kevin
    Yang, Shan
    Hart, Reece
    Monzon, Federico
    Ellisen, Leif
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [8] Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations
    Wood, Marie E.
    Garber, Judy E.
    Isaacs, Claudine
    Masood, Shahla
    Bedrosian, Isabelle
    Tung, Nadine
    Chun, Jennifer
    Schnabel, Freya R.
    Arun, Banu K.
    BREAST JOURNAL, 2019, 25 (04): : 575 - 577
  • [9] The changing landscape of genetic testing for hereditary breast and ovarian cancer
    Bellcross, Cecelia A.
    CURRENT PROBLEMS IN CANCER, 2014, 38 (06) : 209 - 215
  • [10] Genetic Counseling for Hereditary Breast and Ovarian Cancer Among Puerto Rican Women Living in the United States
    Scherr, Courtney L.
    Vasquez, Elsa
    Quinn, Gwendolyn P.
    Vadaparampil, Susan T.
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (04) : 245 - 253